On the use of comprehensive tumor proteomics to identify cancer targets and biology hiding beyond DNA and RNA.
Quantify specific proteins with sequence-confirmed accuracy – without the antibody limitations of ELISA.
Directly measuring the layers of functional tumor biology that shape how a tumor behaves and responds to treatment.
Mapping pathway‑level mechanisms & molecular drivers behind signatures observed via high-content imaging.
Uncovering meaningful physiological differences among patients who appear similar by diagnosis or lab values.
On closing the gap between molecular measurement & clinical meaning, rapidly extracting actionable biological signals.
PharmaShots delves into Sapient’s mission to transform multi-omics research through innovation & world-class partnerships.
Sharing analytical strategies to ensure omics datasets generate insights that are both truthful & actionable.
Bridging the gap from large-scale omics data generation to deep characterization of disease & treatment biomarkers.
Why PCA quality assessment workflows are critical to generating credible insights from high-dimensional omics data.
Why careful metadata preprocessing is key ensure insights derived from downstream analysis are accurate & reproducible.
How metabolite biomarkers can speed GLP-1 agonist time-to-market & drive competitive advantages via novel insights.
